These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 204983)

  • 1. B-cell activating properties of polymyxin B.
    Smith CI; Hammarström L
    Scand J Immunol; 1978; 7(1):67-72. PubMed ID: 204983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymyxins as inhibitors of polyclonal B-cell activators in murine lymphocyte cultures.
    Butler T; Smith E; Hammarström L; Möller G
    Infect Immun; 1977 May; 16(2):449-55. PubMed ID: 193787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of human interleukin-1 production by polymyxin B.
    Damais C; Jupin C; Parant M; Chedid L
    J Immunol Methods; 1987 Jul; 101(1):51-6. PubMed ID: 3039003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between mitogenicity and immunogenicity of 4-hydroxy-3,5-dinitrophenacetyl-lipopolysaccharide, a T-independent antigen.
    Smith E; Hammarström L; Coutinho A
    J Exp Med; 1976 Jun; 143(6):1521-7. PubMed ID: 178823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [DNA synthesis and antibody formation in spleen cells of the mouse after in vivo immunization by Escherichia coli lipopolysaccharide modified by polymyxin B].
    Dufer J; Benoist H; Choppin J; Desplaces A
    C R Seances Acad Sci D; 1980 Mar; 290(11):699-701. PubMed ID: 6247077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of human MLR by very low concentrations of lipopolysaccharide and blocking of this enhancement by polymyxin B.
    Spear GT; Teodorescu M
    J Immunol Methods; 1984 Oct; 73(2):321-7. PubMed ID: 6092477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of thymus-independent immunocyte triggering. Mitogenic activation of B cells results in specific immune responses.
    Coutinho A; Gronowicz E; Bullock WW; Möller G
    J Exp Med; 1974 Jan; 139(1):74-92. PubMed ID: 4128449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of polymyxin-B on T-lymphocyte protein synthesis.
    Baliga BS; Sindel LJ; Jenkins LD; Sachen JB
    Biochem Biophys Res Commun; 1986 Mar; 135(2):649-54. PubMed ID: 3008731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro inhibition of lipopolysaccharide-induced bone resorption by polymyxin B.
    Harvey W; Wilson M; Meghji S
    Br J Exp Pathol; 1986 Oct; 67(5):699-705. PubMed ID: 3024692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of polymyxin B and C3H/HeJ mouse spleen cells as criteria for endotoxin contamination.
    Morrison DC; Curry BJ
    J Immunol Methods; 1979 May; 27(1):83-92. PubMed ID: 222847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the mitogenic response to lipopolysaccharide (LPS) in mouse spleen cells by polymyxin B.
    Jacobs DM; Morrison DC
    J Immunol; 1977 Jan; 118(1):21-7. PubMed ID: 187699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of b-lymphocyte activation: failure to obtain evidence of a direct role of the Ig receptors in the triggering process.
    Möller G; Coutinho A; Persson U
    Scand J Immunol; 1975; 4(1):37-52. PubMed ID: 49077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymyxin B causes coordinate inhibition of phorbol ester-induced C-kinase activity and proliferation of B lymphocytes.
    Nel AE; Wooten MW; Goldschmidt-Clermont PJ; Miller PJ; Stevenson HC; Galbraith RM
    Biochem Biophys Res Commun; 1985 May; 128(3):1364-72. PubMed ID: 2988537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between bacterial endotoxin and human B cell-activating factor.
    Wood DD; Cameron PM
    J Immunol; 1978 Jul; 121(1):53-60. PubMed ID: 353197
    [No Abstract]   [Full Text] [Related]  

  • 15. Dissociation between mitogenicity and immunogenicity of TNP-lipopolysaccharide, a T-independent antigen.
    Jacobs MD; Morrison DC
    J Exp Med; 1975 Jun; 141(6):1453-8. PubMed ID: 165259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymyxin B prevents lipopolysaccharide-induced release of tumor necrosis factor-alpha from alveolar macrophages.
    Stokes DC; Shenep JL; Fishman M; Hildner WK; Bysani GK; Rufus K
    J Infect Dis; 1989 Jul; 160(1):52-7. PubMed ID: 2543712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyxin B suppresses the endotoxin inhibition of concanavalin a-mediated erythrocyte agglutination.
    Warren JR
    Infect Immun; 1982 Feb; 35(2):594-9. PubMed ID: 6276306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoglycosides and polymyxin B as inhibitors of antigen attachment to erythrocytes for agglutination by Salmonella antibodies.
    Neter E; Boulden R
    Immunol Commun; 1981; 10(4-5):395-9. PubMed ID: 6277771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-coated sheep erythrocytes suppress the ability of polyclonal B-cell activators to induce plaque-forming cells against sheep erythrocytes.
    Holmgren M; Möller G
    Scand J Immunol; 1980; 11(1):85-91. PubMed ID: 9537033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the mechanism of peptidoglycan- and lipopolysaccharide-induced polyclonal activation.
    Dziarski R
    Infect Immun; 1982 Feb; 35(2):507-14. PubMed ID: 6460001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.